The safety of nivolumab for advanced melanoma
Challenges and opportunities for patients with advanced NSCLC
Establishing guidelines for categorizing nodules in lung cancer screening
Negative results from trial of roniciclib compared to platinum-based chemotherapy for SCLC
Is mobile symptom monitoring the way forward for patients receiving radiotherapy?